Novartis' meningitis B vaccine wins breakthrough therapy status in U.S.
ZURICH (Reuters) - Novartis said U.S. health regulators have granted the Swiss drugmaker's meningitis B vaccine Bexsero breakthrough therapy status.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/VAQhvGJO7wY/story01.htm
No comments:
Post a Comment